Newborn affected by maternal use of other drugs of addiction

This code identifies a newborn whose health status is directly influenced by the mother's use of illicit or non-prescribed addictive substances during pregnancy. This includes a broad range of substances beyond those specifically classified as anesthesia or analgesia, leading to potential adverse effects on the neonate. The impact may manifest as various physiological or developmental issues in the newborn.

This code is appropriate when documentation clearly links a newborn's condition to maternal use of addictive drugs such as opioids, cocaine, methamphetamine, or other non-therapeutic substances. It should be used when the newborn is affected by the maternal drug use, even if overt withdrawal symptoms are not yet present or are coded separately. Supporting documentation would include maternal history of substance abuse and clinical findings in the neonate attributable to in-utero exposure.

• Do not use this code if the newborn's symptoms are solely due to withdrawal; refer to the Excludes2 note for the appropriate code for withdrawal symptoms.
• Ensure documentation specifies "other drugs of addiction" to differentiate from maternal anesthesia/analgesia exposure.
• Sequence this code as a secondary diagnosis when the primary reason for admission is another condition, unless the maternal drug exposure is the primary focus of care.